{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:11Z","timestamp":1792686251872,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["PDTS2024B-07"],"award-info":[{"award-number":["PDTS2024B-07"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004572","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["GWJJ2022100301"],"award-info":[{"award-number":["GWJJ2022100301"]}],"id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014418","name":"Harbin Medical University Cancer Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["R04009"],"award-info":[{"award-number":["R04009"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178167","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:53:02Z","timestamp":1758055982000},"page":"178167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Erianin induces apoptosis of thyroid cancer cells via TNF signaling pathway"],"prefix":"10.1016","volume":"1006","author":[{"given":"Nailin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2411-5369","authenticated-orcid":false,"given":"Ju","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Lai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178167_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/thy.2010.0021","article-title":"Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006","volume":"21","author":"Aschebrook-Kilfoy","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.ejphar.2025.178167_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.178167_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-020-0149-3","article-title":"Erianin, a novel dibenzyl compound in dendrobium extract, inhibits lung cancer cell growth and migration via calcium\/calmodulin-dependent ferroptosis","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178167_bib4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.178167_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101991","article-title":"The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells","volume":"45","author":"Chen","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejphar.2025.178167_bib6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/ijms25021201","article-title":"An overview of advances in rare cancer diagnosis and treatment","volume":"25","author":"Christyani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178167_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc3465","article-title":"Caspase-8-dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-Induced lethality","volume":"6","author":"Demarco","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2025.178167_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(21)00581-7","article-title":"The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the global burden of disease study 2019","volume":"23","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2025.178167_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041053","article-title":"The death receptor pathway of apoptosis","volume":"14","author":"Green","year":"2022","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejphar.2025.178167_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1089\/thy.2013.0057","article-title":"Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation","volume":"23","author":"Kim","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.ejphar.2025.178167_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature24037","article-title":"Cancer drug addiction is relayed by an ERK2-dependent phenotype switch","volume":"550","author":"Kong","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178167_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/1541-7786.MCR-18-0327","article-title":"Hyperactivation of MAPK signaling is deleterious to RAS\/RAF-mutant melanoma","volume":"17","author":"Leung","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178167_bib13","first-page":"5006","article-title":"Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2025.178167_bib14","article-title":"Erianin: a phytoestrogen with therapeutic potential","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178167_bib15","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/bph.14816","article-title":"Natural compounds as potential adjuvants to cancer therapy: preclinical evidence","volume":"177","author":"Lin","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178167_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopha.2018.12.081","article-title":"Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma","volume":"111","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178167_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12935-024-03533-9","article-title":"Erianin inhibits the progression of pancreatic cancer by directly targeting AKT and ASK1","volume":"24","author":"Liu","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2025.178167_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.764263","article-title":"PPT1 reduction contributes to erianin-induced growth inhibition in oral squamous carcinoma cells","volume":"9","author":"Luo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178167_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45741-9","article-title":"Systematic pharmacology-based strategy to explore the mechanism of Semen strychni for treatment of papillary thyroid carcinoma","volume":"13","author":"Mao","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178167_bib20","first-page":"443","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.178167_bib21","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3390\/molecules24152727","article-title":"Erianin inhibits proliferation and induces apoptosis of HaCaT cells via ROS-mediated JNK\/c-Jun and AKT\/mTOR signaling pathways","volume":"24","author":"Mo","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.178167_bib22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.aau2818","article-title":"Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death","volume":"362","author":"Orning","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178167_bib23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.apsb.2021.12.022","article-title":"Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy","volume":"12","author":"Pan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2025.178167_bib24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMc1215697","article-title":"BRAF V600E inhibition in anaplastic thyroid cancer","volume":"368","author":"Rosove","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178167_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ceb.2020.02.004","article-title":"New insights into the regulation of apoptosis, necroptosis, and pyroptosis by receptor interacting protein kinase 1 and caspase-8","volume":"63","author":"Schwarzer","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178167_bib26","doi-asserted-by":"crossref","DOI":"10.47852\/bonviewMEDIN32021516","article-title":"Bioinformatics analysis identifies potential hub genes, therapeutic agents and crucial pathways in the pathogenesis of refsum's disease","author":"Sharma","year":"2023","journal-title":"Medinfo"},{"key":"10.1016\/j.ejphar.2025.178167_bib27","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/cbin.11684","article-title":"The effect and mechanism of erianin on the reversal of oxaliplatin resistance in human Colon cancer cells","volume":"45","author":"Su","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejphar.2025.178167_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","article-title":"Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-Mutant anaplastic thyroid cancer","volume":"36","author":"Subbiah","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.178167_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.trecan.2020.05.009","article-title":"Clinical development of BRAF plus MEK inhibitor combinations","volume":"6","author":"Subbiah","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ejphar.2025.178167_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.178167_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41392-023-01329-3","article-title":"Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1\/2","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178167_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116295","article-title":"Research progress on the pharmacological mechanism, in vivo metabolism and structural modification of erianin","volume":"173","author":"Wei","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178167_bib33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178167_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaoto.2022.5045","article-title":"Association of treatment strategies and tumor characteristics with overall survival among patients with anaplastic thyroid cancer: a single-institution 21-Year experience","volume":"149","author":"Wu","year":"2023","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.ejphar.2025.178167_bib35","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210093","article-title":"Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K\/Akt pathway","volume":"41","author":"Xu","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2025.178167_bib36","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193137","article-title":"Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K\/AKT, p38 and ERK MAPK signaling pathways","volume":"40","author":"Yang","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2025.178167_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113598","article-title":"Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity","volume":"273","author":"Yang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2025.178167_bib38","article-title":"LC-MS\/MS method for the determination of erianin in rat plasma: application to a pharmacokinetic study","volume":"34","author":"Yi","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejphar.2025.178167_bib39","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1002\/ptr.7154","article-title":"Erianin inhibits human lung cancer cell growth via PI3K\/Akt\/mTOR pathway in vitro and in vivo","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.178167_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation: advances in drug discovery and clinical practice","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178167_bib41","first-page":"141","article-title":"Liquid chromatographic-mass spectrometry analysis and pharmacokinetic studies of erianin for intravenous injection in dogs","volume":"59","author":"Zhou","year":"2009","journal-title":"Arzneimittelforschung"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:34:53Z","timestamp":1780202093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"alternative-id":["S0014299925009215"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178167","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erianin induces apoptosis of thyroid cancer cells via TNF signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178167"}}